A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Clinical trial NCT04915950 · TERMINATED
Trial details
- NCT number
- NCT04915950
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2022-09-02
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.